About Centrose

Centrose is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer and other hard to treat diseases.

To do this, Centrose developed the first-ever synergistic drug targeting system called the Extracellular Drug Conjugate System or EDC. The company’s first product, EDC-One (CEN-106010), is a highly-effective drug which targets many types of late-stage cancers, including lung cancer, the most common cause of cancer death.